Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4995 SEK | -3.76% | -5.40% | -57.31% |
19/04 | AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract | MT |
09/04 | AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas | MT |
Sales 2021 | 13.28 145.04 1.11K | Sales 2022 | 1.71 18.63 142.29 | Capitalization | 42.8M 467M 3.57B |
---|---|---|---|---|---|
Net income 2021 | -92M -1B -7.67B | Net income 2022 | -363M -3.96B -30.28B | EV / Sales 2021 | 7,20,19,947 x |
Net cash position 2021 | 32.63M 356M 2.72B | Net cash position 2022 | 7.44M 81.19M 620M | EV / Sales 2022 | 2,07,30,843 x |
P/E ratio 2021 |
-9.29
x | P/E ratio 2022 |
-0.11
x | Employees | 13 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.58% |
1 day | -3.76% | ||
1 week | -5.40% | ||
Current month | -31.90% | ||
1 month | -29.55% | ||
3 months | -48.53% | ||
6 months | -44.59% | ||
Current year | -57.31% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Witteveen
CEO | Chief Executive Officer | - | 15/23/15 |
Director of Finance/CFO | - | 19/23/19 | |
Vasiliki Fragkou
COO | Chief Operating Officer | - | 01/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 01/20/01 | |
Chairman | 67 | 01/19/01 | |
Sofia Bertling
BRD | Director/Board Member | 54 | 01/22/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.4995 | -3.76% | 26 358 |
26/24/26 | 0.519 | +4.74% | 38,405 |
25/24/25 | 0.4955 | +0.92% | 95,441 |
24/24/24 | 0.491 | -1.80% | 323,437 |
23/24/23 | 0.5 | -5.30% | 205,924 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 12:53 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-57.31% | 1.46M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+1.25% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- AEGIR Stock